Title of article
Case Report: Recurrent High-Dose Intravenous Methylprednisolone Succinate Pulse Therapy-Induced Hepatopathy in a Patient with Multiple Sclerosis
Author/Authors
Furutama, Daisuke Osaka Medical College - Department of Medicine, Japan , Furutama, Daisuke Aino Institute for Aging Research, Japan , Kimura, Fumiharu Osaka Medical College - Department of Internal Medicine, Japan , Shinoda, Keiichi Osaka Medical College - Department of Internal Medicine, Japan , Maeda, Tamaki Osaka Medical College - Department of Nursing, Japan , Tanaka, Toshifumi Aino Institute for Aging Research, Japan , Ohsawa, Nakaaki Osaka Medical College - Department of Internal Medicine, Japan , Ohsawa, Nakaaki Aino Institute for Aging Research, Japan
From page
291
To page
293
Abstract
Objective: We describe recurrent and reversible hepatopathy in a girl with multiple sclerosis (MS) after glucocorticoid pulse therapy, to point out the possibility that glucocorticoid may harm the liver. Clinical Presentation and Intervention: An 11-year-old girl with MS, who was treated with high-dose methylprednisolone succinate pulse therapy, developed elevation of liver enzymes. The episodes of hepatopathy occurred 1–5 weeks after the therapy and disappeared within several weeks. The examination for antinuclear antibody and viruses which can cause hepatitis produced negative results. Conclusion: The present case emphasizes the possible effects of high-dose glucocorticoids in the induction of liver enzymes and the importance of follow-up liver tests after pulse therapy.
Keywords
Demyelination , Dexamethasone phosphate , Intravenous pulse therapy , Toxic hepatitis
Journal title
Medical Principles and Practice
Journal title
Medical Principles and Practice
Record number
2694718
Link To Document